Benitec Biopharma (BNTC) Change in Account Payables (2019 - 2025)

Benitec Biopharma has reported Change in Account Payables over the past 7 years, most recently at $701000.0 for Q4 2025.

  • Quarterly results put Change in Account Payables at $701000.0 for Q4 2025, down 46.16% from a year ago — trailing twelve months through Dec 2025 was -$2.5 million (down 1283.18% YoY), and the annual figure for FY2025 was -$2.4 million, down 352.71%.
  • Change in Account Payables reached $701000.0 in Q4 2025 per BNTC's latest filing, up from $125000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.6 million in Q1 2021 and bottomed at -$3.8 million in Q1 2025.
  • Median Change in Account Payables over the past 5 years was $533000.0 (2022), compared with a mean of $115900.0.
  • The largest annual shift saw Change in Account Payables surged 376.95% in 2021 before it tumbled 466.51% in 2024.
  • Over 5 years, Change in Account Payables stood at $853000.0 in 2021, then crashed by 164.48% to -$550000.0 in 2022, then soared by 307.45% to $1.1 million in 2023, then rose by 14.11% to $1.3 million in 2024, then crashed by 46.16% to $701000.0 in 2025.
  • Business Quant data shows Change in Account Payables for BNTC at $701000.0 in Q4 2025, $125000.0 in Q3 2025, and $484000.0 in Q2 2025.